Summit Therapeutics, AstraZeneca, Daiichi Sankyo Collaborate on Ivonescimab Trial
Summit Therapeutics announced a clinical trial collaboration with AstraZeneca and Daiichi Sankyo to evaluate ivonescimab, an investigational PD-1 / VEGF bispecific antibody, in combination with Datroway.